Harm reduction among people who inject drugs in Mexico

Carlos Magis-Rodríguez, José Alfredo García-Sánchez, Rodrigo Marín-Navarrete

DOI: https://doi.org/10.17711/SM.0185-3325.2018.023

Abstract


Scientific evidence indicates over time that the use of alcohol, tobacco, and other drugs produces a strong impact on the health of those who use them, in addition to being associated
with multiple familial, social, political, and economic issues. Therefore, the high morbidity and mortality rates associated with the use of alcohol, tobacco, and other drugs
increase the burden of disease and the associated disability (Whiteford et al., 2013).


Full Text:

HTML Pdf ePub Xml

References


Centro Nacional para la Prevención y Control del VIH/SIDA & Consejo Nacional contra las Adicciones. (2008). Manual para la prevención del VIH/SIDA en usuarios de drogas inyectadas. Retrieved from: https://www.gob.mx/cms/uploads/attachment/file/27337/manual_udi2008.pdf

Comisión Nacional Contra las Adicciones, Centro Nacional para la Prevención y el Control de las Adicciones, & Comisión Interamericana para el Control del Abuso de Drogas. (2011). Diagnóstico Nacional de Servicios de Tratamiento Residencial de las Adicciones: Perfil del Recurso Humano vinculado al Tratamiento de Personas con Problemas Relacionados al Abuso y Dependencia a Drogas y Perfil del Usuario. México: CONADIC.

European Monitoring Centre for Drugs and Drug Addiction. (2018). Drug consumption rooms: an overview of provision and evidence. Perspectives on drugs. Retrieved from: http://www.emcdda.europa.eu/system/files/publications/2734/POD_Drug%20consumption%20rooms.pdf

International Harm Reduction Association. (2010). What is Harm Reduction? A position statement from the International Harm Reduction Association. IHRA Briefing. Retrieved from: https://www.hri.global/files/2010/08/10/Briefing_What_is_HR_English.pdf

Joint United Nations Programme on HIV and AIDS. (2014). THE GAP REPORT 2014: people who inject drugs. Retrieved from: http://www.unaids.org/sites/default/files/media_asset/05_Peoplewhoinjectdrugs.pdf

Joint United Nations Programme on HIV and AIDS. (2015). UNAIDS terminology guidelines. Retrieved from: http://www.unaids.org/sites/default/files/media_asset/2015_terminology_guidelines_en.pdf

Joint United Nations Programme on HIV and AIDS. (2016). Political Declaration on HIV and AIDS: On the Fast-Track to Accelerating the Fight against HIV and to Ending the AIDS Epidemic by 2030. (General Assembly: A/RES/70/266). Retrieved from: http://www.unaids.org/en/resources/documents/2016/2016-political-declaration-HIV-AIDS

Magis, C., & Barrientos, H. (2009). VIH/SIDA y salud pública. Manual para personal de salud. México: Centro Nacional para la Prevención y el Control del VIH/SIDA & Instituto Nacional de Salud Pública (INSP). Retrieved from: http://www.censida.salud.gob.mx/descargas/biblioteca/manualvihsidaysaludpub.pdf

Marín-Navarrete, R., Magis-Rodríguez, C., Medina-Mora, M.E. & Uribe-Zúñiga, P.E. (2018). Guía para la detección, orientación y referencia del VIH y otras ITS. (In press). México: Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz & Centro Nacional para la Prevención y Control del VIH/SIDA.

Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., ... Vickerman, P. (2016). Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis. The Lancet infectious diseases, 16(7), 797-808. doi: 10.1016/ S1473-3099(15)00485-5

Rhodes, T. & Hedrich, D. (2010). Harm reduction: evidence, impacts and challenges. EMCDDA Monographs. Lisboa: European Monitoring Centre for Drugs and Drug Addiction. Retrieved from: http://www.emcdda.europa.eu/attachements.cfm/att_101257_EN_EMCDDA-monograph10-harm%20reduction_final.pdf

Romero-Mendoza, M., Medina-Mora, M.E., González, H., Vásquez, J., Armas, G., & Magis-Rodríguez, C. (2016). Guía para el uso de metadona en usuarios adultos con VIH dependientes de la heroína intravenosa. México: Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz & Centro Nacional para la Prevención y Control del VIH/SIDA.

Secretaría de Salud & Centro Nacional para la Prevención y Control del VIH/SIDA. (2017). Informe Nacional del monitoreo de compromisos y objetivos ampliados para poner fin al Sida (Informe GAM). Ciudad de México: Secretaría de Salud. Retrieved from: https://www.gob.mx/cms/uploads/attachment/file/299498/Informe_GAM_Mex_2017_DEF.pdf

Secretaría de Salud. (2009). Norma Oficial Mexicana NOM-028-SSA2-2009, para la prevención, tratamiento y control de las adicciones. Ciudad de México: CONADIC. Retrieved from: http://www.conadic.salud.gob.mx/pdfs/norma_oficial_nom.pdf

Strathdee, S., Magis-Rodriguez, C., Mays, V., Jimenez, R., & Patterson, T. (2012). The Emerging HIV Epidemic on the Mexico-U.S. Border: An International Case Study Characterizing the Role of Epidemiology in Surveillance and Response. Annals of Epidemiology, 22(6), 426-438. doi: 10.1016/j.annepidem.2012.04.002

United Nations Office on Drugs and Crime. (2017). Implementing comprehensive HIV and HCV programmes with people who inject drugs: Practical guidance for collaborative interventions. Retrieved from: http://www.who.int/hiv/pub/idu/IDUIT_2017.pdf?ua=1

Villatoro-Velázquez, J. A., Reséndiz-Escobar, E., Mujica-Salazar, A., Bretón-Cirett, M., Cañas-Martínez, V., Soto-Hernández, I., … Mendoza-Alvarado, L. (2017). Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016-2017. Retrieved from: https://www.gob.mx/salud%7Cconadic/acciones-y-programas/encuesta-nacional-de-consumo-de-drogas-alcohol-y-tabaco-encodat-2016-2017-136758

Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., ... Vos, T. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. The Lancet, 382(9904), 1575-1586. doi: 10.1016/S0140-6736(13)61611-6

Wood, E., Werb, D., Kazatchkine, M., Kerr, T., Hankins, C., Gorna, R., ... Montaner, J. (2010). Vienna Declaration: A call for evidence-based drug policies. The Lancet, 376(9738), 310-312. doi: 10.1016/S0140-6736(10)60958-0

World Health Organization. 2016. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations-2016 update. World Health Organization. Retrieved from: http://apps.who.int/iris/bitstream/handle/10665/246200/9789241511124-eng.pdf?sequence=1